Works matching IS 0195668X AND DT 2025 AND VI 46 AND IP 14


Results: 17
    1
    3
    4
    6
    7
    8
    9
    10
    11

    Empagliflozin in resistant hypertension and heart failure with preserved ejection fraction: the EMPEROR-Preserved trial.

    Published in:
    European Heart Journal, 2025, v. 46, n. 14, p. 1304, doi. 10.1093/eurheartj/ehae938
    By:
    • Böhm, Michael;
    • Butler, Javed;
    • Coats, Andrew;
    • Lauder, Lucas;
    • Mahfoud, Felix;
    • Filippatos, Gerasimos;
    • Ferreira, João Pedro;
    • Pocock, Stuart J;
    • Brueckmann, Martina;
    • Hauske, Sibylle J;
    • Schueler, Elke;
    • Wanner, Christoph;
    • Verma, Subodh;
    • Zannad, Faiez;
    • Packer, Milton;
    • Anker, Stefan D
    Publication type:
    Article
    12
    13
    14
    15

    Sodium-glucose co-transporter 2 inhibitors and new-onset diabetes in cardiovascular or kidney disease.

    Published in:
    European Heart Journal, 2025, v. 46, n. 14, p. 1321, doi. 10.1093/eurheartj/ehae780
    By:
    • Ostrominski, John W;
    • Lassen, Mats C Højbjerg;
    • Claggett, Brian L;
    • Miao, Zi Michael;
    • Inzucchi, Silvio E;
    • Docherty, Kieran F;
    • Desai, Akshay S;
    • Jhund, Pardeep S;
    • Køber, Lars;
    • Ponikowski, Piotr;
    • Sabatine, Marc S;
    • Lam, Carolyn S P;
    • Martinez, Felipe A;
    • Boer, Rudolf A de;
    • Hernandez, Adrian F;
    • Shah, Sanjiv J;
    • Petersson, Magnus;
    • Langkilde, Anna Maria;
    • McMurray, John J V;
    • Solomon, Scott D
    Publication type:
    Article
    16
    17